These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26392022)

  • 41. Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience.
    Jin MK; Cho JH; Kwon O; Hong KD; Choi JY; Yoon SH; Park SH; Kim YL; Kim CD
    Transplant Proc; 2012 Jan; 44(1):200-3. PubMed ID: 22310614
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients.
    Drakos SG; Kfoury AG; Long JW; Stringham JC; Fuller TC; Nelson KE; Campbell BK; Gilbert EM; Renlund DG
    Ann Thorac Surg; 2006 Sep; 82(3):889-93. PubMed ID: 16928502
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
    Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Excellent renal allograft survival in donor-specific antibody transplant patients--role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Dhanda R; Shah Y; Bardapure M; Bhattacharjya S; Sharma AK
    Transplantation; 2009 Aug; 88(3):444. PubMed ID: 19667954
    [No Abstract]   [Full Text] [Related]  

  • 45. Renal transplantation in patients with positive lymphocytotoxicity crossmatches: one center's experience.
    Magee CC; Felgueiras J; Tinckam K; Malek S; Mah H; Tullius S
    Transplantation; 2008 Jul; 86(1):96-103. PubMed ID: 18622284
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of Facial Vascularized Composite Allotransplantation in Burn Patients.
    Bharadia D; Sinha I; Pomahac B
    Clin Plast Surg; 2017 Oct; 44(4):857-864. PubMed ID: 28888310
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival.
    Ramirez AE; Cheng HY; Lao WW; Wang YL; Wen CJ; Wallace CG; Lin CF; Shih LY; Chuang SH; Wei FC
    Transpl Int; 2014 Sep; 27(9):977-86. PubMed ID: 24861714
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes in highly sensitized pediatric heart transplant patients using current management strategies.
    Asante-Korang A; Amankwah EK; Lopez-Cepero M; Ringewald J; Carapellucci J; Krasnopero D; Berg A; Quintessenza J; Jacobs JP
    J Heart Lung Transplant; 2015 Feb; 34(2):175-81. PubMed ID: 25447583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transplantation in the highly sensitized pediatric patient.
    Castleberry C; Ryan TD; Chin C
    Circulation; 2014 Jun; 129(22):2313-9. PubMed ID: 24891624
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.
    Asante-Korang A; Jacobs JP; Ringewald J; Carapellucci J; Rosenberg K; McKenna D; McCormack J; Wilmot I; Gjeldum A; Lopez-Cepero M; Sleasman J
    Cardiol Young; 2011 Dec; 21 Suppl 2():124-32. PubMed ID: 22152539
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transplantation of the broadly sensitized patient: what are the options?
    Böhmig GA; Wahrmann M; Bartel G
    Curr Opin Organ Transplant; 2011 Dec; 16(6):588-93. PubMed ID: 21971512
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The contribution of the donor vascularised hand and face allograft in transplant rejection: An immunological perspective.
    Amin KR; Fildes JE
    Transpl Immunol; 2024 Jun; 84():102035. PubMed ID: 38518826
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biomarker and surrogate development in vascularised composite allograft transplantation: Current progress and future challenges.
    Honeyman C; Stark H; Wang HC; Hester J; Issa F; Giele H
    J Plast Reconstr Aesthet Surg; 2021 Apr; 74(4):711-717. PubMed ID: 33436335
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recent developments in desensitization of crossmatch-positive kidney transplant recipients.
    Morath C; Opelz G; Zeier M; Süsal C
    Transplant Proc; 2012; 44(6):1648-51. PubMed ID: 22841236
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnosing skin rejection in vascularized composite allotransplantation: advances and challenges.
    Sarhane KA; Khalifian S; Ibrahim Z; Cooney DS; Hautz T; Lee WP; Schneeberger S; Brandacher G
    Clin Transplant; 2014 Mar; 28(3):277-85. PubMed ID: 24476538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intravenous immunoglobulins and transplantation for patients with anti-HLA antibodies.
    Glotz D; Antoine C; Julia P; Pegaz-Fiornet B; Duboust A; Boudjeltia S; Fraoui R; Combes M; Bariety J
    Transpl Int; 2004 Jan; 17(1):1-8. PubMed ID: 14685653
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Kinetics of cellular and humoral immunity in a successful case of positive crossmatch kidney transplantation: a case report.
    Tanimine N; Ide K; Yamashita M; Tanaka Y; Igarashi Y; Banshodani M; Tazawa H; Basnet NB; Doskali M; Onoe T; Tashiro H; Ohdan H
    Transplant Proc; 2011; 43(6):2411-4. PubMed ID: 21839279
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Editorial: Sensitization and Desensitization in Organ Transplantation.
    Anwar IJ; Jackson AM; Locke JE; Kwun J
    Front Immunol; 2021; 12():784472. PubMed ID: 34721444
    [No Abstract]   [Full Text] [Related]  

  • 59. Factors associated with and predictive of persistence of donor-specific antibody after treatment with plasmapheresis and intravenous immunoglobulin.
    Zachary AA; Montgomery RA; Leffell MS
    Hum Immunol; 2005 Apr; 66(4):364-70. PubMed ID: 15866699
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Desensitization for sensitized patients awaiting heart transplant.
    Byku M; Chang PP
    Curr Opin Organ Transplant; 2019 Jun; 24(3):233-238. PubMed ID: 31090629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.